Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
1,347.11
-4.01 (-0.30%)
Official Closing Price
Updated: 7:00 PM EST, Nov 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Eli Lilly
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Beyond GLP-1: The Next Wave of Peptide Innovation Could Unlock Billions in Biotech Growth
November 19, 2026
GLP-1 Treatments, Anticancer Research, and Emerging Therapeutic Technologies Are Driving the Next Chapter of Pharmaceutical Innovation
From
FN Media
Via
GlobeNewswire
Beyond GLP-1: The Next Wave of Peptide Innovation Could Unlock Billions in Biotech Growth
November 19, 2026
EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(NYSE:LLY),(NYSE:HIMS),(TSXV:PAIN),(CSE:VLAB) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Intellectual Property
New Analysis Explains What Lilly’s ObesityWeek 2026 EloraTZP Results Add to the September Phase 2b Readout and What They Leave Unchanged
November 17, 2026
Via
Press Release Distribution Service
A Billionaire Investor Links Cancer Treatment and Wireless Technology as AI Pharmaceutical Testing Gains Ground
November 11, 2026
Via
AB Newswire
Topics
Artificial Intelligence
Gabelli Releases Agenda for 8th Annual Healthcare Symposium
November 09, 2026
From
Gabelli Funds
Via
GlobeNewswire
New Independent Research Hub Launches for Eloralintide, Lilly’s Investigational Amylin Agonist
November 09, 2026
Via
Press Release Distribution Service
Topics
Supply Chain
Certified PEP MEX Expands Its Reach in Mexico With Two New Research Peptide Websites
November 07, 2026
Via
Press Release Distribution Service
Lilly and Hims & Hers expand access to FDA-approved Lilly medicines
November 06, 2026
From
Hims & Hers
Via
Business Wire
Peptide Therapies Are Changing the Future of Medicine — And the Market Could Reach $335 Billion
November 03, 2026
Growing Demand for Next-Generation Therapies Is Putting Peptide Innovation at the Center of Healthcare's Biggest Growth Markets
From
FN Media
Via
GlobeNewswire
Peptide Therapies Are Changing the Future of Medicine — And the Market Could Reach $335 Billion
November 03, 2026
EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(OTCQX:RHHBY),(NYSE:NVO),(NASDAQ:VKTX),(NYSE:LLY) EQNX::TICKER_END
Via
FinancialNewsMedia
Retatrutide Research Draws Attention in Costa Rica as Demand for Reliable Scientific Information Grows
November 03, 2026
Via
Press Release Distribution Service
The $294 Billion Peptide Boom: Biotech Companies Positioned for the Next Wave of Growth
October 29, 2026
Breakthroughs in obesity, diabetes, oncology, and targeted therapies are driving fresh interest in peptide-based medicines and the companies developing the next generation of treatments.
From
FN Media
Via
GlobeNewswire
The $294 Billion Peptide Boom: Biotech Companies Positioned for the Next Wave of Growth
October 29, 2026
EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(NYSE:NVO),(NYSE:HIMS),(NYSE:ENHA),(NYSE:LLY) EQNX::TICKER_END
Via
FinancialNewsMedia
Wound Care Stocks Are Posting Double-Digit Growth. Here’s Why.
October 06, 2026
From
Wall Street Investor
Via
GlobeNewswire
2026 Biotech Watchlist IBRX, PACB, IGC, VIVS Lead 7 Stocks in Focus
October 01, 2026
Via
AB Newswire
2026 Nanocap Stocks to Watch: IGC, KNRX, GYGY, ARAY Lead Watchlist Now See More Inside!
September 28, 2026
Via
AB Newswire
Topics
Artificial Intelligence
VivoSim Labs Inc. (NASDAQ: VIVS) Targets the Multibillion-Dollar Cost of Failed Drugs
September 28, 2026
Via
AB Newswire
VivoSim Labs Inc. (NASDAQ: VIVS) Takes Aim at Pharma’s 92% Drug-Failure Problem
September 21, 2026
Via
AB Newswire
Topics
Animal Testing
VivoSim Labs (NASDAQ: VIVS): Predicting Drug Toxicity Before Human Clinical Trials
September 10, 2026
Via
AB Newswire
2025 R&D Spending And Intensity Benchmarks
September 09, 2026
Via
PRLog
Topics
Supply Chain
VivoSim Labs (NASDAQ: VIVS): 10,000 Compounds to 1 Drug with AI-Powered 3D Human Toxicology
August 26, 2026
Via
AB Newswire
Topics
Artificial Intelligence
Nasdaq 30’s VIVS, IGC, RIME, AIXI Stocks Now
August 26, 2026
Via
AB Newswire
Topics
Artificial Intelligence
VivoSim Labs (NASDAQ: VIVS) Research Report Highlights AI-Powered Drug Toxicity Platform, FDA NAM Momentum
August 25, 2026
Via
AB Newswire
Topics
Animal Testing
Artificial Intelligence
Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.
August 19, 2026
News Provided by USA News Group on behalf of MindWalk Holdings Corp.
From
USA News Group
Via
GlobeNewswire
A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It.
August 18, 2026
From
Equity Insider
Via
GlobeNewswire
VivoSim Labs (NASDAQ: VIVS) Among IGC, OSRH, IVF as FDA-Backed Human-Based Testing Gains Momentum
August 17, 2026
Via
AB Newswire
Topics
Animal Testing
Artificial Intelligence
The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For
August 12, 2026
News Provided by USA News Group on behalf of Conexeu Sciences Inc.
From
USA News Group
Via
GlobeNewswire
Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates
July 21, 2026
EQNX::TICKER_START (NASDAQ:HELP),(NASDAQ:CMPS),(NASDAQ:ATAI),(NYSE:JNJ),(NYSE:LLY) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Artificial Intelligence
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AtaiBeckley Inc. (Nasdaq – ATAI), Distribution Solutions Group, Inc. (Nasdaq – DSGR), Cross Country Healthcare, Inc. (Nasdaq – CCRN), Nuvalent, Inc. (Nasdaq – NUVL)
July 16, 2026
From
Brodsky & Smith LLC
Via
GlobeNewswire
As Medicare’s New GLP-1 Coverage Begins, Ozari Health Publishes 2026 Guide Comparing Every Way to Get Semaglutide and Tirzepatide – From $50 Copays to $86 Cash-Pay Options
July 15, 2026
Via
AB Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit